CN Patent

CN102228691A — 阿司匹林和一种抗血小板药物的药物组合物

Assigned to Beijing Fukangren Bio Pharm Tech Co Ltd · Expires 2011-11-02 · 15y expired

What this patent protects

本发明为阿司匹林和一种抗凝药物的药物组合物，是以阿司匹林和另外一种具有抗凝活性的药物为活性成分，与药学上适宜的辅料组合而成。所述的抗凝物质包括，替卡格雷、普拉格雷、阿那格雷、奥扎格雷、坎格雷洛等。本发明所述的组合物可制成口服制剂，用于治疗和/或预防各种心脑血管事件的发生。

USPTO Abstract

本发明为阿司匹林和一种抗凝药物的药物组合物，是以阿司匹林和另外一种具有抗凝活性的药物为活性成分，与药学上适宜的辅料组合而成。所述的抗凝物质包括，替卡格雷、普拉格雷、阿那格雷、奥扎格雷、坎格雷洛等。本发明所述的组合物可制成口服制剂，用于治疗和/或预防各种心脑血管事件的发生。

Drugs covered by this patent

Patent Metadata

Patent number
CN102228691A
Jurisdiction
CN
Classification
—
Expires
2011-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.